s6y
Company name or ticker
Search
Orexigen Therapeutics, Inc.
4
NARACHI MICHAEL: Statement of changes in beneficial ownership of securities
Filed
Friday, December 2, 2016
Period
Nov 30, 2016
Accession number
0001209191-16-153095
Documents
FORM 4 SUBMISSION
4
POA DOCUMENT
EX-24.4_687194
On sec.gov
Filing index
All files
Complete submission text
SGML header